WestEnd Advisors’s Boston Scientific BSX Stock Holding History

WestEnd Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.88K	Buy	44 +6	+16%	+$326	﹤0.01%	193
2026 Q1	$2.38K	Hold	38	–	–	﹤0.01%	142
2025 Q4	$3.62K	Sell	38 -6	-14%	-$588	﹤0.01%	117
2025 Q3	$4.3K	Sell	44 -20	-31%	-$2.07K	﹤0.01%	106
2025 Q2	$6.87K	Buy	64 +7	+12%	+$708	﹤0.01%	89
2025 Q1	$5.75K	Buy	57 +38	+200%	+$3.83K	﹤0.01%	89
2024 Q4	$1.7K	Buy	19 +2	+12%	+$176	﹤0.01%	108
2024 Q3	$1.43K	Sell	17 -1	-6%	-$79	﹤0.01%	106
2024 Q2	$1.39K	Sell	18 -5	-22%	-$366	﹤0.01%	101
2024 Q1	$1.57K	Buy	23 +1	+5%	+$64	﹤0.01%	97
2023 Q4	$1.27K	Buy	22 +2	+10%	+$107	﹤0.01%	108
2023 Q3	$1.06K	Buy	+20	New	+$1.05K	﹤0.01%	106
2023 Q1	–	Sell	-18	Closed	-$848	–	109
2022 Q4	$833	Hold	18	–	–	﹤0.01%	109
2022 Q3	$1K	Hold	18	–	–	﹤0.01%	100
2022 Q2	$670	Buy	+18	New	+$733	﹤0.01%	125
2022 Q1	–	Sell	-11	Closed	-$477	–	138
2021 Q4	$467	Buy	+11	New	+$462	﹤0.01%	161
2021 Q3	–	Hold	0	–	–	–	151
2021 Q2	–	Hold	0	–	–	–	154

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

WestEnd Advisors's BSX Position: Q2 2026 in Review

WestEnd Advisors increased its Boston Scientific (BSX) stake by 16% in Q2 2026, buying an estimated $326 and bringing the position to 44 shares worth $1.88K. The position accounts for ﹤0.01% of the portfolio, ranked #193.

WestEnd Advisors first reported a position in BSX in Q4 2021 and has held it in 16 quarters since. The position peaked at $6.87K in Q2 2025. 1,476 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

WestEnd Advisors held 44 shares of Boston Scientific worth $1.88K as of Q2 2026.
WestEnd Advisors bought 6 Boston Scientific shares in Q2 2026, an estimated $326.
Boston Scientific made up ﹤0.01% of WestEnd Advisors's portfolio in Q2 2026, its #193 holding.
WestEnd Advisors first reported a position in Boston Scientific in Q4 2021 and has held it in 16 quarters since.
WestEnd Advisors's Boston Scientific position peaked at $6.87K in Q2 2025.
1,476 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on WestEnd Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.